The Neuropathic Pain Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Neuropathic Pain Market?
The market for neuropathic pain has seen robust growth in recent times. The market size is set to increase from $5.35 billion in 2024 to $5.79 billion in 2025, with a compound annual growth rate (CAGR) of 8.2%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Neuropathic Pain Industry?
The Neuropathic Pain Global Market Report 2025 anticipates that by 2029, the market size for neuropathic pain will reach $7.76 billion. This represents a compound annual growth rate (CAGR) of 7.6%.
Download Your Free Sample of the 2025 Neuropathic Pain Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Neuropathic Pain Market?
The key drivers in the neuropathic pain market are:
• Rising awareness about neuropathic pain
• Increase in the aging population
• Access to neuropathic pain treatments
• Advanced diagnostics and pain management techniques
Global Market Segmentation: Identifying Major Neuropathic Pain Industry Segments
The neuropathic pain market covered in this report is segmented –
1) By Treatment: Medications, Multimodal Therapy
2) By Diagnosis: Imaging, Blood Tests And Physical Examination
3) By Indication: Diabetic Neuropathy, Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Other Indications
4) By End User: Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Other End Users
Pre-order the 2025 Neuropathic Pain Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Neuropathic Pain Market?
The key trends in the neuropathic pain market are:
• The market is witnessing improved diagnostic methods for neuropathic pain.
• Advancements in pain management techniques are influencing the market significantly.
• Medical research advancements are shaping the future of neuropathic pain treatments.
• The introduction of new drug approvals and strategic initiatives is a growing trend in the market.
Who Are the Top Competitors & Leading Players in the Neuropathic Pain Market?
Major companies in the neuropathic pain market are:
• Pfizer Inc.
• Johnson & Johnson Private Limited
• Sanofi S.A.
• Bristol-Myers Squibb Company
• Abbott Laboratories
• GlaxoSmithKline PLC
• Medtronic Inc.
• Eli Lilly and Company
• Stryker Corporation
• Baxter International Inc.
• Teva Pharmaceutical Industries Ltd.
• Boston Scientific Corporation
• Biogen Inc.
• Zimmer Biomet Holdings Inc.
• Sun Pharmaceutical Industries Ltd.
• Mallinckrodt Pharmaceuticals
• Grünenthal GmbH
• Lupin Ltd.
• NuVasive Inc.
• Integer Holdings Corporation
• Avanos Medical Inc.
• Orthofix Medical Inc.
• Nevro Corp.
• InvaGen Pharmaceuticals Inc.
• B. Braun Melsungen AG
• Cirtec Medical Corp.
• Centaur Pharmaceuticals Pvt Ltd.
• Stimwave LLC
• DePuy Synthes.
Regional Dominance: Which Area Leads the Global Neuropathic Pain Market?
North America was the largest region in the neuropathic pain market in 2024
